期刊文献+

肺炎嗜衣原体MOMP和人IL-2融合基因DNA疫苗的免疫原性研究 被引量:3

Immunogenicity of the DNA vaccine with monogene and fusion gene of the major outer membrane protein in Chlamydia pneumoniae and human IL-2
下载PDF
导出
摘要 目的构建肺炎嗜衣原体(Chlamydophila pneumoniae,Cpn)主要外膜蛋白(MOMP)单基因及momp和人IL-2融合基因的真核表达载体并比较其免疫反应性,为研制Cpn核酸疫苗提供理论和实验依据。方法扩增Cpn momp及人IL-2基因并将二者融合,将momp和momp-IL-2分别克隆至pcDNA3.1(+)真核表达载体;制备纳米粒DNA疫苗免疫BALB/c小鼠,免疫荧光组化法检测重组质粒在小鼠组织内的稳定表达;ELISA法检测小鼠血清中的特异性抗体和小鼠脾细胞培养上清中IFN-γ水平;MTT法测定脾淋巴细胞特异性增殖反应。结果成功制备了pcDNA3.1(+)-momp和pcD-NA3.1(+)-momp-IL-2的纳米核酸疫苗;Cpn momp单基因和momp-IL-2融合基因核酸疫苗均能刺激小鼠产生特异性抗体,且pcDNA3.1(+)-momp-IL-2能诱导小鼠产生更高效价的特异性抗体(P<0.05);pcDNA3.1(+)-momp-IL-2诱导小鼠脾细胞产生IFN-γ的量及对特异抗原的刺激指数明显高于pcDNA3.1(+)-momp。结论Cpn momp单基因核酸疫苗和momp-IL-2融合基因核酸疫苗均能刺激小鼠产生较强的体液免疫和细胞免疫应答;pcDNA3.1(+)-momp-IL-2的免疫效果强于pcDNA3.1(+)-momp。 To provide the theoretical and experimental basis for the development of nucleic acid vaccine, the eukaryotic expression vector containing the major outer membrane protein (MOMP) of Chlamydia pneumoniae monogene or its fusion gene with human IL-2 gene was constructed and their immunogenieities were compared. These genes were amplified , fused by recombinant PCR and then cloned into eukaryotic expression vector pcDNA3. 1 (+) to obtain the recombinant plasmid pcD- NA3.1 (-) momp and pcDNA3. 1 (+)-momp-IL-2. BALB/c mice were vaccinated intramuscularly with these two kinds of plasmid combined plasmids respectively. The humoral immune responses of mice after vaccination were determined by ELISA assay and the cell-mediated response was evaluated by the specific proliferative response and the level of IFN-γ of splenic lymphocytes. It was demonstrated that the eukaryotic expression vectors containing the momp gene or the momp-IL-2 fusion gene were successfully constructed and they could elicit production of specific antibodies in the vaccinated mice. The antibody titer e licited by plasmid peDNA3, 1(+)-momp-IL-2 was much higher than that of peDNA3, 1(+)-momp (P〈0.05). In addition, the stimulation index (SI) and the IFNγ level also showed the similar pattern as antibody titer (P〈0.05). It is evident that both the pcDNA3.1 (+)-momp and ptasmid peDNA3.1 (+) can induce strong humoral and cell-mediated immune responses in mice inoculated with these DNA vaccines and the immunogenicity induced by the former were significantly higher than that of the latter.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2009年第9期837-841,共5页 Chinese Journal of Zoonoses
基金 湖南省科技厅重点资助项目(06FJ2004) 湖南省卫生厅重点课题(A2003-2006)
关键词 肺炎嗜衣原体 外膜蛋白 核酸疫苗 Chlamydophila pneumoniae major outer membrane protein nucleic acid vaccine
  • 相关文献

参考文献15

  • 1Miyashita N. Chlamydia pneumoniae infections[J]. Kekkaku, 2006,81(9):581-588.
  • 2Didion SP. Chlamydophila pneumoniae and endothelial activation: the smoke that precedes the fire of atherosclerosis [J]. Cite Res, 2008,102(8) : 861-863.
  • 3Marino J, Stoeckli I, Walch M,et al. Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells [J]. BMC Mierobiol, 2008,8:32.
  • 4Watson C, Alp NJ. Role of Chlamydia pneumoniae in atheroselerosis[J]. Clin Sci (Lond) ,2008,114(8) :509-531.
  • 5Essig A, Simnaeher U, Susa M, et al. Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation[J]. Clin Diagn Lab Immunol, 1999, 6 (6) :819-825.
  • 6Juul N, Timmerman E, Gevaert K, et al. Proteolytic cleavage of the Chlamydia pneumoniae major outer membrane protein in the absence of Pmp10[J]. Proteomics,2007,7(24) :4477-4487.
  • 7Hugle B, Suchowerskyj P, Schuster V. Varicella vaccination: who should be vaccinated these days[J]. MMW Fortschritte Der Medizin,2005,147(8) : 31-32.
  • 8Roy K,Mao HQ, Huang SK, et al. Oral gene delivery with chitosan DNA nanoparticles generates immunologic protection in a murine model of peanut alergy [J]. Nat Med, 1999, 5 (4): 387-391.
  • 9李学荣,余新炳.核酸疫苗及其免疫机制研究[J].中国人兽共患病杂志,2000,16(6):82-86. 被引量:22
  • 10方艳辉,金玉怀,王永祥,于丹军,金士香,谢立新.人IL-2信号肽基因增强柯萨奇病毒B3型VP1 DNA疫苗诱导的中和抗体应答[J].中华微生物学和免疫学杂志,2004,24(3):202-205. 被引量:11

二级参考文献18

  • 1Wang R,Plasmids Infect Immun,1998年,66卷,9期,4193页
  • 2Yang W,Biochem Biolphys Res Commun,1995年,212卷,3期,1029页
  • 3Xu D,J Lmajor Immunology,1995年,84卷,1期,173页
  • 4Xiang Z Q,Virology,1994年,199卷,1期,132页
  • 5Wang B,DNA Cell Biol,1993年,12卷,9期,799页
  • 6Wang B,Proc Nat Acad Sci SUA,1993年,90卷,9期,4156页
  • 7Tang D C,Nature,1992年,356卷,636期,152页
  • 8Yang N S,Proc Nat Acad Sci SUA,1990年,87卷,24期,9568页
  • 9Jack F, Woodruff MD. Viral myocarditis. A review. Am J Pathol, 1980, 101 (2): 425-484.
  • 10Bowles NE, Olsen EGJ, Richardson PJ, et al. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet, 1986, 1: 1120-1123.

共引文献31

同被引文献88

  • 1程驰,章欢,赵先平,高荣.DNA疫苗安全性的策略探究[J].四川动物,2012,31(2):328-331. 被引量:2
  • 2周红莉,郭丽,王健伟,洪涛.粘膜免疫佐剂研究进展[J].中国生物工程杂志,2006,26(3):83-88. 被引量:13
  • 3李臻,金宁一,金洪涛,沈国顺,付延军,辛苏文,韩贞珍,刘玉生.HIV多表位核酸疫苗构建及其免疫原性[J].中国生物制品学杂志,2007,20(3):178-180. 被引量:3
  • 4付延军,金宁一,金洪涛,李臻,辛苏文,李萍,韩贞珍,李太元.DNA表达载体构建及HIV多表位核酸疫苗的设计与表达[J].中国生物制品学杂志,2007,20(4):237-239. 被引量:2
  • 5Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization [J]. Science, 1996, 273 (5273) : 352-354.
  • 6Leitner WW, Ying H, Driver DA, et al. Enhancement of tumorspecific immune response with plasmid DNA replicon vectors [J]. Cancer Res, 2000, 60 (1): 51-55.
  • 7Roy M J, Wu MS, Barr LJ, et al. Induction of antigen-specific CD8+ T cells, T helper ceils, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine [J]. Vaccine, 2000, 19 (7-8): 764-778.
  • 8Drape RJ, Macklin MD, Barr LJ, et al. Epidermal DNA vaccine for influenza is immunogenic in humans [J]. Vaccine, 2006, 24 (21) : 4475-4481.
  • 9Tavel JA, Martin JE, Kelly GG, et al. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects [J]. J Acquir Immune Defic Syndr, 2007, 44 (5): 601-605.
  • 10Otten G, Schaefer M, Doe B, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation [J]. Vaccine, 2004, 22 (19): 2489-2493.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部